Mai Peptide
Ipamorelin
Finnrick tested 4 samples of Ipamorelin (GHS agonist) from Mai Peptide between 21 Aug 2025 and 6 Jan 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Mai Peptide
Ipamorelin
Tested 4 Samples
Last test 6 Jan 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Ipamorelin tests from top-rated vendors:
All Ipamorelin tests from Mai Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
6 Jan 2026
First
21 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 Jan 2026 | View | 5mg | 4.76mg | -4.8% | 81.60% | (no batch ID) | Silver Label / Silver Crimp / Red Cap | Lab E | Public | |
| 17 Dec 2025 | View | 10mg | 10mg | 99.85% | 08-28-2025 | White Label / Silver Crimp / Blue Cap | Lab E | Public | ||
| 21 Aug 2025 | View | 10mg | 10.5mg | +5.0% | 99.95% | (no batch ID) | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |